Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2018-06-25 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
2017年度第三期超短期融资券兑付完成公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the completion of repayment (兑付完成公告) of a short-term financing bond issued by the company. It includes details such as bond code, issuance date, amount, interest rate, and repayment date. The document length is only 610 characters, indicating it is a brief notice rather than a detailed financial report. It does not contain financial statements or detailed analysis but rather informs about a financing event completion. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2018-06-25 Chinese
2018年第二次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, attendance, and voting procedures of a company's 2018 second extraordinary general meeting of shareholders. It details the legality and validity of the meeting's procedures, attendees, and voting results, including election of board members and amendments to company articles. The document is not a report of financial results, audit, or management discussion, but rather a legal opinion on the shareholder meeting and its resolutions. It includes detailed voting results and confirms the legality of the meeting and its outcomes. This type of document corresponds to Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of a shareholder meeting.
2018-06-21 Chinese
2018年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2018 second extraordinary shareholders' meeting of Huabang Life Health Co., Ltd. It includes voting results on amendments to the company bylaws, election of board members and supervisors, and legal opinions confirming the validity of the meeting and voting procedures. The content focuses on the outcomes of shareholder votes and changes in board composition. There is no financial data or report content, but rather official voting results and governance changes. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)', which covers official results from shareholder votes at any general meeting. The document length is 3384 characters, which is consistent with a detailed voting results announcement rather than a full report or presentation. Therefore, the correct classification is DVA with high confidence.
2018-06-21 Chinese
2018年第一次职工代表大会会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of a new employee representative supervisor to the company's supervisory board, including details about the meeting and the elected individual's resume. It does not contain financial data, audit information, or regulatory filings related to financial performance. It is a corporate governance-related announcement about board composition changes, specifically the supervisory board. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on management changes, not a full report or announcement of a report publication.
2018-06-20 Chinese
关于召开2018年第二次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement about the convening of the 2018 second extraordinary general meeting (临时股东大会) of Huabang Life Health Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), agenda items such as amendments to the company charter and board/supervisory committee elections, registration details, and proxy forms. The document does not contain financial statements or results but serves as a notice and procedural guide for shareholders to participate in the meeting and vote on resolutions. It is not a report of voting results, nor is it a management or financial report. Given the content and purpose, this document fits the category of a Proxy Solicitation & Information Statement (PSI), which provides shareholders with information and requests votes for meetings.
2018-06-12 Chinese
2014年公司债券（第一期）2018年付息公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the interest payment on a corporate bond issued by 华邦生命健康股份有限公司. It details the bond's basic information, interest rate, payment dates, tax implications, and the entities involved in the payment process. The document does not contain financial statements or comprehensive financial performance data but focuses on the specifics of the bond interest payment event. The length is about 3118 characters, which is relatively short and typical for an announcement. This fits the description of a Capital/Financing Update (CAP), as it relates to bond interest payment and financing activities rather than a full financial report or regulatory filing. Therefore, the appropriate classification is CAP with high confidence.
2018-06-08 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.